Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Upstream Bio (UPB) Total Liabilities (2023 - 2025)

Upstream Bio has reported Total Liabilities over the past 3 years, most recently at $14.0 million for Q4 2025.

  • Quarterly results put Total Liabilities at $14.0 million for Q4 2025, up 17.98% from a year ago — trailing twelve months through Dec 2025 was $14.0 million (up 17.98% YoY), and the annual figure for FY2025 was $14.0 million, up 17.98%.
  • Total Liabilities for Q4 2025 was $14.0 million at Upstream Bio, up from $12.6 million in the prior quarter.
  • Over the last five years, Total Liabilities for UPB hit a ceiling of $146.6 million in Q2 2024 and a floor of $9.4 million in Q4 2023.
  • Median Total Liabilities over the past 3 years was $12.4 million (2024), compared with a mean of $47.5 million.
  • Biggest five-year swings in Total Liabilities: rose 26.39% in 2024 and later crashed 92.09% in 2025.
  • Upstream Bio's Total Liabilities stood at $9.4 million in 2023, then grew by 26.39% to $11.9 million in 2024, then grew by 17.98% to $14.0 million in 2025.
  • The last three reported values for Total Liabilities were $14.0 million (Q4 2025), $12.6 million (Q3 2025), and $11.8 million (Q2 2025) per Business Quant data.